Literature DB >> 25879670

Nedd4-induced monoubiquitination of IRS-2 enhances IGF signalling and mitogenic activity.

Toshiaki Fukushima1, Hidehito Yoshihara2, Haruka Furuta3, Hiroyasu Kamei3, Fumihiko Hakuno3, Jing Luan4, Cunming Duan5, Yasushi Saeki6, Keiji Tanaka6, Shun-Ichiro Iemura7, Tohru Natsume8, Kazuhiro Chida3, Yusuke Nakatsu9, Hideaki Kamata9, Tomoichiro Asano9, Shin-Ichiro Takahashi3.   

Abstract

Insulin-like growth factors (IGFs) induce proliferation of various cell types and play important roles in somatic growth and cancer development. Phosphorylation of insulin receptor substrate (IRS)-1/2 by IGF-I receptor tyrosine kinase is essential for IGF action. Here we identify Nedd4 as an IRS-2 ubiquitin ligase. Nedd4 monoubiquitinates IRS-2, which promotes its association with Epsin1, a ubiquitin-binding protein. Nedd4 recruits IRS-2 to the membrane, probably through promoting Epsin1 binding, and enhances IGF-I receptor-induced IRS-2 tyrosine phosphorylation. In thyroid FRTL-5 cells, activation of the cyclic AMP pathway increases the association of Nedd4 with IRS-2, thereby enhancing IRS-2-mediated signalling and cell proliferation induced by IGF-I. The Nedd4 and IRS-2 association is also required for maximal activation of IGF-I signalling and cell proliferation in prostate cancer PC-3 cells. Nedd4 overexpression accelerates zebrafish embryonic growth through IRS-2 in vivo. We conclude that Nedd4-induced monoubiquitination of IRS-2 enhances IGF signalling and mitogenic activity.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25879670     DOI: 10.1038/ncomms7780

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  34 in total

1.  Hippo-mediated suppression of IRS2/AKT signaling prevents hepatic steatosis and liver cancer.

Authors:  Sun-Hye Jeong; Han-Byul Kim; Min-Chul Kim; Ji-Min Lee; Jae Ho Lee; Jeong-Hwan Kim; Jin-Woo Kim; Woong-Yang Park; Seon-Young Kim; Jae Bum Kim; Haeryoung Kim; Jin-Man Kim; Hueng-Sik Choi; Dae-Sik Lim
Journal:  J Clin Invest       Date:  2018-02-05       Impact factor: 14.808

2.  Cezanne contributes to cancer progression by playing a key role in the deubiquitination of IGF-1R.

Authors:  Xiaowei Chen; Zhaofei Pang; Yu Wang; Linhai Zhu; Jichang Liu; Jiajun Du
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

3.  Identification of a Novel Invasion-Promoting Region in Insulin Receptor Substrate 2.

Authors:  Jose Mercado-Matos; Jenny Janusis; Sha Zhu; Samuel S Chen; Leslie M Shaw
Journal:  Mol Cell Biol       Date:  2018-06-28       Impact factor: 4.272

4.  NEDD4 ubiquitin ligase is a putative oncogene in endometrial cancer that activates IGF-1R/PI3K/Akt signaling.

Authors:  Yuping Zhang; Renee Goodfellow; Yujun Li; Shujie Yang; Christopher J Winters; Kristina W Thiel; Kimberly K Leslie; Baoli Yang
Journal:  Gynecol Oncol       Date:  2015-07-17       Impact factor: 5.482

Review 5.  Functional roles of E3 ubiquitin ligases in prostate cancer.

Authors:  Yiting Zhao; Jinyun Li; Jun Chen; Meng Ye; Xiaofeng Jin
Journal:  J Mol Med (Berl)       Date:  2022-07-11       Impact factor: 5.606

6.  Suppressor of Cytokine Signaling (SOCS)1 Regulates Interleukin-4 (IL-4)-activated Insulin Receptor Substrate (IRS)-2 Tyrosine Phosphorylation in Monocytes and Macrophages via the Proteasome.

Authors:  Sarah M McCormick; Nagaraj Gowda; Jessie X Fang; Nicola M Heller
Journal:  J Biol Chem       Date:  2016-08-09       Impact factor: 5.157

7.  Monoubiquitination of Cancer Stem Cell Marker CD133 at Lysine 848 Regulates Its Secretion and Promotes Cell Migration.

Authors:  Fan Yang; Yang Xing; Yinan Li; Xiaoning Chen; Jianhai Jiang; Zhilong Ai; Yuanyan Wei
Journal:  Mol Cell Biol       Date:  2018-07-16       Impact factor: 4.272

Review 8.  Diversity of insulin and IGF signaling in breast cancer: Implications for therapy.

Authors:  Michael W Lero; Leslie M Shaw
Journal:  Mol Cell Endocrinol       Date:  2021-02-17       Impact factor: 4.102

9.  The E3 ligase TRAF4 promotes IGF signaling by mediating atypical ubiquitination of IRS-1.

Authors:  Wenjuan Yu; Ramesh Singh; Zhao Wang; Bert W O'Malley; Ping Yi
Journal:  J Biol Chem       Date:  2021-05-13       Impact factor: 5.157

Review 10.  Post-Translational Modifications That Drive Prostate Cancer Progression.

Authors:  Ivana Samaržija
Journal:  Biomolecules       Date:  2021-02-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.